Fundz

Who to call at AVITA Medical, Inc., and when

Fundz watches for the moments AVITA Medical, Inc. starts buying, and tells you who to reach.

  • An alert the day AVITA Medical, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AVITA Medical, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AVITA Medical, Inc.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KHIGH RiskNegative

AVITA Medical, Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

avitamedical.com
Filed: Oct 16, 2025Santa Clarita, CaliforniaCIK: 0001762303Biotechnology
Full company profileView on SEC.gov

2 executive changes at Avita Medical in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

AVITA Medical's CEO James Corbett departed as CEO and Board member effective October 16, 2025, with the Company stating the departure was not due to any disagreement. Chairman Cary Vance was appointed Interim CEO while continuing as Chairman, and Jan Reed was named Lead Independent Director, creating a leadership transition the market will watch closely.

Key Takeaways

CEO James Corbett left both his CEO role and his Board seat effective October 16, 2025, and the filing states the departure did not result from any disagreement on operations, policies, or practices.

Chairman Cary Vance was named Interim CEO effective immediately and will also remain Chairman, concentrating executive and board leadership in one person during the interim period.

3 more takeaways

Related Filings (8)

8 more filings from AVITA Medical, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 16, 2025
Item5.02
CategoryExecutive Change
CIK0001762303
Accession #0001762303
Risk LevelHIGH
SentimentNegative
Signalrisk
Topics
executive departureleadership transitionboard change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

AVITA Medical, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.